Bevacizumab in combination with metronomic chemotherapy in patients with anthracycline- and taxane-refractory breast cancer. (Q46231664)
Jump to navigation
Jump to search
scientific article published in October 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Bevacizumab in combination with metronomic chemotherapy in patients with anthracycline- and taxane-refractory breast cancer. |
scientific article published in October 2008 |
Statements
Bevacizumab in combination with metronomic chemotherapy in patients with anthracycline- and taxane-refractory breast cancer (English)
M Martín
C Bueno
L Rodríguez
J Bobokova
A Custodio
1 reference
1 reference
1 reference
1 reference